[covid-19 community levels help individuals and communities decide what prevention steps to take based on hospitalizations and cases., check community levels, learn more about the high-level framework for planning and prioritization of covid-19 work., brief summaries of new covid-19 studies on many topics, science briefs on new and emerging topics, all science briefs, interactive maps and charts of covid-19 cases, deaths, and trends in the us, interactive data about covid-19 vaccination uptake, attitudes, and confidence, , , results from covid-19 outbreak investigations, articles on covid-19 and chronic disease, studies of covid-19 since the beginning of the pandemic, to find a list of content that has been archived for historical purposes, please visit our archive. please note the content of these pages and files may be out of date as they are no longer being updated. view archive., to receive email updates about covid-19, enter your email address:, español, 繁體中文, tiếng việt, 한국어, tagalog, русский, العربية, kreyòl ayisyen, français, polski, português, italiano, deutsch, 日本語, فارسی, english][science and research, covid-19 by county]science and research | cdc[, ., have questions?, cdc information, connect with cdc, language assistance, links with this icon indicate that you are leaving the cdc website.][home, your health, vaccines, cases & data, work & school, healthcare workers, health depts, science, more, current update, previous updates, weekly review, forecasting, variant surveillance, view all data & surveillance, covid-19 community levels, transmission of sars-cov-2 in k-12 schools, community use of masks, effectiveness of a covid-19 additional primary or booster vaccine dose in preventing sars-cov-2 infection among nursing home residents during widespread circulation of the omicron variant — united states, february 14–march 27, 2022, seroprevalence of infection-induced sars-cov-2 antibodies — united states, september 2021–february 2022, provisional covid-19 age-adjusted death rates, by race and ethnicity — united states, 2020–2021, provisional mortality data — united states, 2021, hospitalizations of children aged 5–11 years with laboratory-confirmed covid-19 — covid-net, 14 states, march 2020–february 2022, effectiveness of covid-19 mrna vaccination in preventing covid-19–associated hospitalization among adults with previous sars-cov-2 infection — united states, june 2021–february 2022, covid-19 mortality and vaccine coverage — hong kong special administrative region, china, january 6, 2022–march 21, 2022, facebook, twitter, linkedin, syndicate, science agenda for covid-19, weekly reviewplus icon past weekly reports, past weekly reports, science briefsplus icon science brief: indicators for monitoring covid-19 community levels and making public health recommendations science brief: omicron (b.1.1.529) variant sars-cov-2 infection-induced and vaccine-induced immunity covid-19 vaccines and vaccination sars-cov-2 transmission sars-cov-2 and surface (fomite) transmission for indoor community environments transmission of sars-cov-2 in k-12 schools emerging sars-cov-2 variants evidence for conditions that increase risk of severe illness use of masks to control the spread of sars-cov-2, science brief: indicators for monitoring covid-19 community levels and making public health recommendations, science brief: omicron (b.1.1.529) variant, sars-cov-2 infection-induced and vaccine-induced immunity, covid-19 vaccines and vaccination, sars-cov-2 transmission, sars-cov-2 and surface (fomite) transmission for indoor community environments, transmission of sars-cov-2 in k-12 schools, emerging sars-cov-2 variants, evidence for conditions that increase risk of severe illness, use of masks to control the spread of sars-cov-2, covid data tracker, covid-19 community levels, forecastingplus icon omicron potential spread case forecastsplus icon previous case forecasts death forecastsplus icon previous death forecasts hospital forecastsplus icon previous hospitalization forecasts forecasting: background, omicron potential spread, case forecastsplus icon previous case forecasts, previous case forecasts, death forecastsplus icon previous death forecasts, previous death forecasts, hospital forecastsplus icon previous hospitalization forecasts, previous hospitalization forecasts, forecasting: background, variant surveillanceplus icon genomic surveillance for sars-cov-2 tracking emerging variants sars-cov-2 variant classifications and definitions sequencing for sars-cov-2 (spheres), genomic surveillance for sars-cov-2, tracking emerging variants, sars-cov-2 variant classifications and definitions, sequencing for sars-cov-2 (spheres), data improvements, about epidemiologyplus icon studying the disease identifying the outbreak source monitoring the disease developing guidance for public health, studying the disease, identifying the outbreak source, monitoring the disease, developing guidance for public health, cdc covid-19 dataplus icon about cdc covid-19 data covid-19 data sources faq data & surveillance previous us case data previous testing data, about cdc covid-19 data, covid-19 data sources, faq data & surveillance, previous us case data, previous testing data, guidance for covid-19plus icon search guidance documents, search guidance documents, archive, about cdc, jobs, funding, policies, file viewers & players, other languages, privacy, foia, no fear act, oig, nondiscrimination, accessibility, vulnerability disclosure policy | español, facebook, twitter, instagram, linkedin, snapchat, youtube, syndicate, cdc tv, rss, email, about cdc, jobs, funding, policies, file viewers & players, other languages, privacy, foia, no fear act, oig, nondiscrimination, accessibility, vulnerability disclosure policy | español, cdc website exit disclaimer external icon, español, 繁體中文, tiếng việt, 한국어, tagalog, русский, العربية, kreyòl ayisyen, français, polski, português, italiano, deutsch, 日本語, فارسی, english, facebook, twitter, instagram, linkedin, snapchat, youtube, syndicate, cdc tv, rss, email, the centers for disease control and prevention (cdc) cannot attest to the accuracy of a non-federal website., linking to a non-federal website does not constitute an endorsement by cdc or any of its employees of the sponsors or the information and products presented on the website., you will be subject to the destination website's privacy policy when you follow the link., cdc is not responsible for section 508 compliance (accessibility) on other federal or private website.]